Immuno-priming with bevacizumab: durvalumab plus bevacizumab after prolonged exposition to bevacizumab in breast cancer
Ontology highlight
ABSTRACT: Immuno-priming with bevacizumab: durvalumab plus bevacizumab after prolonged exposition to bevacizumab in breast cancer
PROVIDER: PRJNA578152 | ENA |
REPOSITORIES: ENA
ACCESS DATA